conference reporter

62nd ASH Annual Meeting and Exposition

Conference Reporter in Multiple Myeloma to Cover Key Topics Being Presented at the 62nd ASH Annual Meeting and Exposition

by Tom Iarocci, MD

Overview

Conference Reporter  delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. This issue of Conference Reporter  will feature coverage of selected topics in Multiple Myeloma presented at this year’s ASH annual meeting.

“As the story of antibody-based and immune-based therapies continues to unfold, there is optimism for novel combinations that might address significant unmet needs in the treatment of multiple myeloma.”

Tom Iarocci, MD

The clinicians who were surveyed selected the following expert commentators and topics from the upcoming conference.

Community-Selected Expert Commentators: 

Robert Z. Orlowski, MD, PhD

Director of Myeloma Section
Department of Lymphoma/Myeloma
Florence Maude Thomas Cancer Research Professor
Department of Experimental Therapeutics
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

S. Vincent Rajkumar, MD

Edward W. and Betty Knight Scripps Professor of Medicine
Mayo Clinic
Rochester, MN

Paul G. Richardson, MD

Clinical Program Leader and Director of Clinical Research
Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute
RJ Corman Professor of Medicine
Harvard Medical School
Boston, MA

Community-Selected Topics: 

  • Novel and Emerging Therapeutic Strategies for Multiple Myeloma
  • Chimeric Antigen Receptor T-Cell Therapies, Bispecific Antibodies, and Antibody Conjugates
  • Frail and/or Older Patients With Multiple Myeloma: ASH 2020 Roundup
  • Multiple Myeloma Treatment Challenges: Immunoglobulin Light Chain Amyloidosis at ASH 2020
  • Expanding Horizons: Antibody-Based Therapy in Multiple Myeloma
  • Research to Address Unmet Needs in Multiple Myeloma


This information is brought to you by Engage Health Media and is not sponsored by, nor a part of, the American Society of Hematology. 

More in Multiple Myeloma

Thumb

Multiple Myeloma

Conference Reporter in Multiple Myeloma to Cover Key Topics Being Presented at the ASCO20 Virtual Scientific Program and the Virtual Edition of the 25th EHA Annual Congress

Conference Reporter by Tom Iarocci, MD

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, ...READ MORE

Thumb

Multiple Myeloma

Multiple Myeloma Session Roundup: Minimal Residual Disease Assessment and Implications

Conference Reporter by Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD; and Paul G. Richardson, MD

Several abstracts and posters on minimal residual disease (MRD) in multiple myeloma were presented at the ASCO20 Virtual Scientific Program, in the...READ MORE

Thumb

Multiple Myeloma

Treatment of Patients With Relapsed and/or Refractory and High-Risk Multiple Myeloma

Conference Reporter by Robert Z. Orlowski, MD, PhD; S. Vincent Rajkumar, MD; and Paul G. Richardson, MD

Several abstracts and posters focused on relapsed/refractory and high-risk multiple myeloma were presented at the ASCO20 Virtual Scientific Program...READ MORE

More In Conference Reporter

Metastatic Prostate Cancer

Promise in Treatment Personalization for Advanced Prostate Cancer

Conference Reporter
by E. David Crawford, MD

Metastatic Prostate Cancer

Metastatic Prostate Cancer: Predictive Biomarkers for Tailored Therapy

Conference Reporter
by E. David Crawford, MD

Metastatic Prostate Cancer

Novel and Emerging Treatments for Progressive Metastatic Castration-Resistant Prostate Cancer

Conference Reporter
by William K. Oh, MD